06.02.08
Dr. Philip William Small has been named managing director of European operations, AMRI. Dr. Small joined the company as director of chemistry in November 2007 to lead all scientific efforts at the Hungarian-based organization. He replaces Dr. Michael Guaciaro, who returns to AMRI’s headquarters in Albany, NY, upon completing a short-term assignment related to the former Hungarian business known as Comgenex, acquired by AMRI in 2006.
“Dr. Small will play a critical role in managing the site’s efforts and focus on increasing profitability and accelerating growth of the business as AMRI seeks to expand its presence in the European marketplace,” said AMRI chief executive officer, Thomas E. D’Ambra, Ph.D. “His prior demonstrated experience in strategic growth, direction and leadership, combined with his knowledge of the AMRI business acquired to date sets the stage for Dr. Small and his team to execute against defined opportunities and plans for the future of our European operations."
Prior to joining AMRI, Dr. Small was vice president and head of high-throughput chemistry operations at Tripos Discovery Research, where he played a major role in growing the company as well as influencing strategic direction and corporate objectives. Dr. Small has more than 20 years of experience leading combinatorial chemistry/drug discovery companies in addition to Tripos including scientific leadership positions at OSI Pharmaceuticals, Oxford Diversity/OAI and Unilever Research.
“Dr. Small will play a critical role in managing the site’s efforts and focus on increasing profitability and accelerating growth of the business as AMRI seeks to expand its presence in the European marketplace,” said AMRI chief executive officer, Thomas E. D’Ambra, Ph.D. “His prior demonstrated experience in strategic growth, direction and leadership, combined with his knowledge of the AMRI business acquired to date sets the stage for Dr. Small and his team to execute against defined opportunities and plans for the future of our European operations."
Prior to joining AMRI, Dr. Small was vice president and head of high-throughput chemistry operations at Tripos Discovery Research, where he played a major role in growing the company as well as influencing strategic direction and corporate objectives. Dr. Small has more than 20 years of experience leading combinatorial chemistry/drug discovery companies in addition to Tripos including scientific leadership positions at OSI Pharmaceuticals, Oxford Diversity/OAI and Unilever Research.
